The novel therapy of the medication represents a significant advance in the handling of type 2 diabetes. Unlike existing medications, tirzepatide impacts dual pathways – the GLP-1 hormone and GIP – providing https://tirzepatidepeptide587910.bloginder.com/42638479/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment